Factors influencing sodium and water excretion in uremic man. 1975

B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls

Urinary excretion of sodium and water was investigated in patients with chronic end-stage renal disease before and after three different experimental manipulations: reduction in urea solute load by dialysis while extracellular fluid volume (ECFV) was maintained, dialysis without alteration in urea solute load or ECFV and reduction in ECFV without alteration in urea solute load. Sodium and water excretion significantly declined in association with a reduction in both urea solute load and ECFV, but not during a dialysis when reduction on both of these indexes was prevented. The excretory changes occurred in the absence of any alteration in creatinine clearance. The studies suggest that both solute load and the degree of extracellular fluid volume expansion contribute independently to the rate of sodium and water excretion in chronic renal disease. It is concluded that in any given patient the overall excretion of sodium and water is directly influenced by a number of factors including the solute load, the degree of ECFV and the glomerular filtration rate.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005110 Extracellular Space Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall. Intercellular Space,Extracellular Spaces,Intercellular Spaces,Space, Extracellular,Space, Intercellular,Spaces, Extracellular,Spaces, Intercellular
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls
January 1974, Acta physiologica latino americana,
B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls
March 1973, Clinical science,
B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls
April 1968, Medical times,
B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls
January 1969, Nephron,
B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls
August 1968, The Journal of clinical investigation,
B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls
March 1968, The Journal of clinical investigation,
B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls
April 1975, The Journal of pharmacy and pharmacology,
B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls
July 1969, Clinica chimica acta; international journal of clinical chemistry,
B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls
October 1958, Northwest medicine,
B P Yeh, and D J Tomko, and W K Stacy, and E S Bear, and H T Haden, and W F Falls
June 1986, Experimental and clinical endocrinology,
Copied contents to your clipboard!